Pages that link to "Q37421142"
Jump to navigation
Jump to search
The following pages link to Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis (Q37421142):
Displaying 50 items.
- Proteinaceous Molecules Mediating Bifidobacterium-Host Interactions (Q26740603) (← links)
- Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease (Q26771122) (← links)
- Claudins in intestines: Distribution and functional significance in health and diseases (Q27000548) (← links)
- Can probiotics benefit children with autism spectrum disorders? (Q28076833) (← links)
- Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis (Q28565067) (← links)
- Can probiotics modulate human disease by impacting intestinal barrier function? (Q28817192) (← links)
- Gut microbiota, probiotics, and human health (Q33666412) (← links)
- Small intestinal intraepithelial TCRγδ+ T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitis (Q33721659) (← links)
- Microecology, intestinal epithelial barrier and necrotizing enterocolitis (Q33730542) (← links)
- Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis (Q34097563) (← links)
- Branched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model (Q34110669) (← links)
- Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota (Q34207172) (← links)
- Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis (Q34360448) (← links)
- Effects of Lactobacillus plantarum on gut barrier function in experimental obstructive jaundice (Q34388382) (← links)
- Microbial ecosystems therapeutics: a new paradigm in medicine? (Q34519313) (← links)
- Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit (Q34525865) (← links)
- Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury (Q34746651) (← links)
- The composition of the gut microbiota throughout life, with an emphasis on early life. (Q35044607) (← links)
- Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants (Q35056256) (← links)
- Probiotics, nuclear receptor signaling, and anti-inflammatory pathways (Q35131051) (← links)
- Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions (Q35150607) (← links)
- Effect of bifidobacterium on defensin-5 expression in intestinal injury of preweaning rats (Q35152314) (← links)
- Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis (Q35168957) (← links)
- The role of intestinal epithelial barrier function in the development of NEC. (Q35318848) (← links)
- Modulation of Intestinal Epithelial Defense Responses by Probiotic Bacteria (Q35550764) (← links)
- Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis. (Q35556323) (← links)
- Secreted Metabolites of Bifidobacterium infantis and Lactobacillus acidophilus Protect Immature Human Enterocytes from IL-1β-Induced Inflammation: A Transcription Profiling Analysis (Q35612905) (← links)
- Intestinal microbiota and its relationship with necrotizing enterocolitis. (Q35636352) (← links)
- Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model (Q35788266) (← links)
- Immature oxidative stress management as a unifying principle in the pathogenesis of necrotizing enterocolitis: insights from an agent-based model. (Q35799174) (← links)
- Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine (Q35849435) (← links)
- Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant (Q35922759) (← links)
- Probiotics in early life: a preventative and treatment approach (Q35958581) (← links)
- Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population (Q36014389) (← links)
- Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function (Q36055022) (← links)
- Recent advances in small bowel diseases: Part I. (Q36093331) (← links)
- Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model (Q36110095) (← links)
- The suckling rat as a model for immunonutrition studies in early life (Q36152172) (← links)
- Bifidobacterium adolescentis protects against necrotizing enterocolitis and upregulates TOLLIP and SIGIRR in premature neonatal rats (Q36241201) (← links)
- Pomegranate seed oil reduces intestinal damage in a rat model of necrotizing enterocolitis (Q36309520) (← links)
- Paneth cells and necrotizing enterocolitis (Q36392091) (← links)
- Probiotics and the gut microbiota in intestinal health and disease (Q36567134) (← links)
- Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? (Q36619112) (← links)
- Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses (Q36747196) (← links)
- In vitro prevention of salmonella lipopolysaccharide-induced damages in epithelial barrier function by various lactobacillus strains (Q36948517) (← links)
- Helicobacter hepaticus increases intestinal injury in a rat model of necrotizing enterocolitis (Q37234765) (← links)
- Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications (Q37396622) (← links)
- Developmental biology of gut-probiotic interaction (Q37843647) (← links)
- Prebiotics to manage the microbial control of energy homeostasis (Q37965353) (← links)
- The interactions between endogenous bacteria, dietary components and the mucus layer of the large bowel. (Q38008242) (← links)